BioCentury
ARTICLE | Company News

Genzyme Molecular in SAGE deal with Invitrogen

October 10, 2000 7:00 AM UTC

GZMO granted IVGN exclusive worldwide rights to sell its Serial Analysis of Gene Expressrion (SAGE) technology in standardized reagent kits. GZMO will receive an upfront payment and royalties. IVGN al...